Attached files

file filename
10-Q - QUARTERLY REPORT - UNIGENE LABORATORIES INCunigene_10q-093010.htm
EX-32.2 - CERTIFICATION - UNIGENE LABORATORIES INCex32-2.htm
EX-10.3 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND GREGORY T. MAYES, DATED SEPTEMBER 12, 2010. - UNIGENE LABORATORIES INCex10-3.htm
EX-31.2 - CERTIFICATION - UNIGENE LABORATORIES INCex31-2.htm
EX-10.1 - SENIOR SECURED CONVERTIBLE TERM NOTE, DATED MARCH 17, 2010 (REISSUED JULY 28, 2010), ISSUED BY THE COMPANY IN FAVOR OF VICTORY PARK CREDIT OPPORTUNITIES MASTER FUND LTD. - UNIGENE LABORATORIES INCex10-1.htm
EX-31.1 - CERTIFICATION - UNIGENE LABORATORIES INCex31-1.htm
EX-10.2 - SENIOR SECURED CONVERTIBLE TERM NOTE, DATED MARCH 17, 2010 (REISSUED JULY 28, 2010), ISSUED BY THE COMPANY IN FAVOR OF VPC FUND II, L.P. - UNIGENE LABORATORIES INCex10-2.htm
 
 
 
Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Unigene Laboratories, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ashleigh Palmer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)           the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)           the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/  Ashleigh Palmer
Ashleigh Palmer
Chief Executive Officer
November 9, 2010

 

A signed original of this written statement required by Section 906 has been provided to Unigene Laboratories, Inc. and will be retained by Unigene Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.